Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
2112737-25-2 | Propargyl-peg10-amine | AA019EB1 | MFCD30730361
2183440-43-7 | Sulfo-Cy3 amine | AA019EFD | MFCD31580127
25742-87-4 | 2,4,4A,5,6,7-Hexahydro-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-one | AA019EIL | MFCD30471750
5555-71-5 | methyl benzyloxycarbamate | AA019ELZ | MFCD00027807
1340052-38-1 | 4-Chloro-5-ethyl-6-(methylsulfanyl)-pyrimidine | AA019EOX | MFCD18874670
409320-89-4 | 3,5-dimethyl-4H-Pyrazole | AA019ERM | MFCD14585425
1823271-85-7 | 5-tert-Butyl 3-ethyl 4H-furo[2,3-c]pyrrole-3,5(6H)-dicarboxylate | AA019EVD | MFCD27997349
868783-62-4 | (N-methyl-N-tert-butoxycarbonyl-aminomethyl)-nitrobenzene | AA019EYN | MFCD11846371
2222-07-3 | Cucurbitacin I | AA019FRQ | MFCD09971044
1260667-07-9 | tert-Butyl 3-chloro-2-formylphenylcarbamate | AA019G88 | MFCD18250357